title: [Surgical decompression treatment of leprous neuritis at the Bom-Pastor Hospital (Brazilian Amazonia)].
abstract: OBJECTIVE
  Only leprosy resource centres undertake surgery for neuritis. Patients' accessibility to this surgical procedure is poor because these centres are often far from their homes. The aim of our work is to study the feasibility of neuritis surgery in the field.
  
  
  METHODS
  A surgeon trained in this surgery was recruited by Bom-Pastor hospital in Brazilian Amazonia, which is located 400 km away from the leprosy resource centre. Patients operated from May 1996 to December 1997 were enrolled in this retrospective study.
  
  
  RESULTS
  A total of 45 operations were carried out during 17 procedures on 13 patients, among which 12 were multibacillary cases. The decompression surgery was performed with a median delay of 1 year after leprosy diagnosis and 3.5 months after the neuritis diagnosis. Among 17 operations, 14 were performed for painful neuritis of recent onset unsuccessfully treated with corticoids or recurring during the month after corticoids were withdrawn. The other three operations were performed for long-standing neuritis with paralysis and deformity. Pain was relieved in all the cases of recent neuritis, except for one patient who suffered from a serious steroid-dependant erythema nodosum leprosum. An improvement of motor function was observed in one out of three patients with long-standing neuritis. Adverse effects were few: a scar infection with a rapid recovery and a keloid scar. Two neurites recurred 2 and 10 months after the surgery.
  
  
  CONCLUSIONS
  In an endemic leprosy region, field access to surgery for neuritis appears to prove real progress in the management of leprosy neuritis.
authors.affiliation: Département de médecine communautaire, CHU, BP 217, 38043 Grenoble, France. matthieu.debray@ujf-grenoble.fr
authors.forename: M
authors.initials: M
authors.lastname: Debray
authors.forename: T
authors.initials: T
authors.lastname: Hanslik
authors.forename: M A
authors.initials: MA
authors.lastname: Avansi
authors.forename: B
authors.initials: B
authors.lastname: Pabion
authors.forename: O
authors.initials: O
authors.lastname: Lortholary
mesh_terms: D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001938:Brazil; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007918:Leprosy / Q000150:complications / Q000601:surgery*; D015439:Leprosy, Borderline / Q000150:complications / Q000601:surgery; D015440:Leprosy, Lepromatous / Q000150:complications / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D011241:Prednisone